Conflicts of Interest
S.M.D. has received research support from Alexion Pharmaceuticals and
has had consultancies with Novartis, Rocket Pharma, CIRM, Allovir, and
Neurogene. C.L.P. has served on an advisory committee for Novartis. The
remaining authors declare no competing financial interests.